LUMINEX CORP|4Jul 21, 6:48 PM ET

Fairchild Nancy 4

4 · LUMINEX CORP · Filed Jul 21, 2020

Form 4

Period: 2020-07-21

Sr Vice President, HR

Transactions

Exercise/Conversion
Common Stock
2020-07-21$19.13/sh+31,235$597,526→ 89,346 total
Exercise/Conversion
Stock Option (Right To Buy)
2020-07-21$19.13/sh−372$7,116→ 0 total
Exercise: $19.13From: 2017-03-22Exp: 2023-03-22→ Common Stock (372 underlying)
Sale
Common Stock
2020-07-21$37.85/sh−372$14,080→ 58,111 total
Exercise/Conversion
Common Stock
2020-07-21$19.13/sh+372$7,116→ 58,483 total
Sale
Common Stock
2020-07-21$37.85/sh−31,235$1,182,245→ 58,111 total
Exercise/Conversion
Common Stock
2020-07-21$18.04/sh+37,675$679,657→ 95,786 total
Sale
Common Stock
2020-07-21$37.85/sh−37,675$1,425,999→ 58,111 total
Exercise/Conversion
Stock Option (Right To Buy)
2020-07-21$19.13/sh−31,235$597,526→ 0 total
Exercise: $19.13From: 2017-03-22Exp: 2023-03-22→ Common Stock (31,235 underlying)
Award
Stock Option (Right To Buy)
2020-07-21$18.04/sh−37,675$679,657→ 12,559 total
Exercise: $18.04From: 2018-03-10Exp: 2024-03-10→ Common Stock (37,675 underlying)

Footnotes (1)

[F1]This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on May 20, 2020. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.

Documents

1 file